Shenzhen Xinxing: The wholly-owned subsidiary's boron trifluoride project has received approval for trial production.

Shenzhen Xinxing announced that the construction of the annual production of 10,000 tons of boron trifluoride gas and 20,000 tons of boron trifluoride complex project by its wholly-owned subsidiary Ganzhou Songhui Fluorine New Materials Co., Ltd. has completed the main engineering construction and equipment installation, commissioning work. The trial production plan and device trial production conditions have been approved by experts and obtained trial production approval. Currently, the project is ready for trial production. Boron trifluoride is mainly used in the production of pharmaceuticals, semiconductors, nuclear power radiation protection, lithium batteries, solid-state battery additives, and high-end chip etching. Additionally, boron trifluoride is also a raw material for boron-10 isotopes, which are mainly used in nuclear reactor control rods, fast reactor control rods, and nuclear waste treatment.